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The level of available iron in the mammalian host is extremely low, and pathogenic microbes must compete with host
proteins such as transferrin for iron. Iron regulation of gene expression, including genes encoding iron uptake
functions and virulence factors, is critical for the pathogenesis of the fungus Cryptococcus neoformans. In this study, we
characterized the roles of the CFT1 and CFT2 genes that encode C. neoformans orthologs of the Saccharomyces
cerevisiae high-affinity iron permease FTR1. Deletion of CFT1 reduced growth and iron uptake with ferric chloride and
holo-transferrin as the in vitro iron sources, and the cft1 mutant was attenuated for virulence in a mouse model of
infection. A reduction in the fungal burden in the brains of mice infected with the cft1 mutant was observed, thus
suggesting a requirement for reductive iron acquisition during cryptococcal meningitis. CFT2 played no apparent role
in iron acquisition but did influence virulence. The expression of both CFT1 and CFT2 was influenced by cAMP-
dependent protein kinase, and the iron-regulatory transcription factor Cir1 positively regulated CFT1 and negatively
regulated CFT2. Overall, these results indicate that C. neoformans utilizes iron sources within the host (e.g., holo-
transferrin) that require Cft1 and a reductive iron uptake system.
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Introduction
Pathogenic microbes such as the fungus Cryptococcus neofor-
mans face a major challenge in acquiring iron during
infection of vertebrate hosts. Free iron in tissues and ﬂuids
is maintained at extremely low levels due to the binding
properties of the host proteins transferrin and lactoferrin.
Moreover, vertebrates use iron deprivation as an important
natural defense strategy against microbial pathogens [1]. For
example, transferrin, which accounts for ;1% of the total
iron in the human body, is maintained at ;33% saturation
with iron in serum and effectively scavenges free iron [2].
Lactoferrin is similar to transferrin in structure and function
but this protein retains iron in acidic conditions, such as at
sites of inﬂammation, whereas transferrin binds iron at
neutral pH [3]. Iron bound to heme is abundant in
mammalian hosts but its availability during fungal patho-
genesis is not yet clear because most of the heme is present in
hemoglobin within erythrocytes. The data presented herein
suggest that heme and transferrin may both be important
iron sources for C. neoformans because each can support the
growth of the fungus in culture.
The mechanisms by which microbes acquire iron during
infection are of considerable interest and are best charac-
terized in bacterial pathogens [4]. For example, many
pathogenic bacteria produce siderophores that bind to ferric
iron with high afﬁnity, and many are able to utilize ferritin,
transferrin, lactoferrin, heme and heme-containing proteins.
In many species, the mechanisms of iron acquisition have
been elucidated in detail and preferences for speciﬁc iron
sources during infection are being identiﬁed. For example,
Staphylococcus aureus preferentially uses iron from heme rather
than from transferrin during infection [5].
Mechanisms of iron acquisition are less well studied in
pathogenic fungi. However, iron transport pathways have
been well characterized in the model fungus Saccharomyces
cerevisiae, which has at least two distinct high-afﬁnity uptake
systems. One is a reductive pathway in which ferric iron is
reduced to ferrous iron by cell surface reductase activity with
subsequent transport across the plasma membrane by the
high-afﬁnity iron permease (Ftr1)–multicopper ferroxidase
(Fet3) complex [6–8]. The second high-afﬁnity iron transport
pathway uses siderophores from other organisms and trans-
ports iron bound to these molecules via cell surface trans-
porters encoded by the ARN gene family [9–11].
Similar iron transport pathways exist in fungal pathogens
of humans, although these have been less well studied. For
example, both the reductive and siderophore iron uptake
systems are found in Candida albicans and Aspergillus fumigatus.
Two orthologous genes of the high-afﬁnity iron permease
FTR1 were identiﬁed in C. albicans and one of them, CaFTR1,
was shown to be required for systemic infection [12]. CaFTR1
also mediates iron acquisition from transferrin [13]. C.
albicans is not able to synthesize siderophores but has
siderophore transporters such as CaArn1/CaSit1. However,
the role of CaArn1/CaSit1 in an infected host may be minimal
because a mutant only showed defects in epithelial invasion
[14]. C. albicans does have hemolytic activity and utilizes heme
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surface proteins that bind heme and hemoglobin have been
identiﬁed in C. albicans [18]. Additionally, this yeast uses
hemoglobin as a signaling molecule to alter gene expression
and to induce adhesion to host cells, and also to trigger the
yeast to hyphae transition that is required for pathogenesis
[19]. However, the question of whether heme or hemoglobin
utilization plays a role in virulence in vivo is still unclear
because none of previous studies showed virulence effects.
Another animal pathogen, A. fumigatus also possesses the high-
afﬁnity iron permease FtrA, but this enzyme is not required
for virulence. In contrast, the A. fumigatus SidA protein, which
is responsible for siderophore synthesis, is essential for
virulence [20,21].
Regulatory mechanisms that govern expression of the high-
afﬁnity iron permease have also been investigated. In S.
cerevisiae, the global transcriptional activator Aft1 activates
expression of FTR1 and other genes of the iron regulon
[22,23]. Interestingly, orthologs of S. cerevisiae FTR1 in other
fungi are negatively regulated by a conserved GATA-type zinc
ﬁnger protein. Thus, the iron permease gene FIP1 is
regulated by Fep1 in Schizosaccharomyces pombe and the
permease gene FER2 is regulated by Urbs1 in Ustilago maydis
[24,25]. We recently identiﬁed and characterized a global
transcriptional regulator, Cir1, in C. neoformans that shows
sequence and functional similarities to Fep1 and Urbs1. We
found that Cir1 regulates many genes for iron acquisition
including genes for putative high-afﬁnity iron permeases, as
well as genes involved in virulence in C. neoformans [26].
It has been suggested that the cAMP pathway inﬂuences
iron uptake by controlling expression of the high-afﬁnity iron
permease in fungi. In S. cerevisiae, the catalytic subunit of
cAMP-dependent protein kinase (PKA), Tpk2, negatively
regulates expression of FTR1 and FET3, and Tpk2 may
indirectly control respiratory growth by negative regulation
of iron uptake [27]. This connection between respiration and
iron uptake is supported by the ﬁnding that the aft1 mutant
fails to grow in the presence of non-fermentable carbon
sources [28,29]. A connection between cAMP and iron uptake
also exists in U. maydis because the expression of FER2 is
positively regulated by the cAMP pathway [24]. Similar
regulatory connections exist in C. neoformans because tran-
scriptome studies demonstrated that genes for reductive iron
uptake are differentially expressed in mutants lacking
components of the cAMP pathway [30].
C. neoformans utilizes several transport systems to acquire
iron from the environment and both high and low afﬁnity
iron uptake activities mediated by cell surface reductases
have been detected [31]. Nonenzymatic reduction of ferric
iron by a secreted reductant, 3-hydroxyanthranilic acid, and
by melanin in the cell wall, may also contribute to iron
acquisition [32]. C. neoformans reportedly does not produce
siderophores but is capable of utilizing iron bound to
siderophores secreted from other microorganisms [31]. The
SIT1 gene, which encodes a siderophore transporter, was
found to mediate siderophore utilization, but the gene is not
required for virulence [33].
In this study, we identiﬁed and functionally characterized
two candidate iron transporters in C. neoformans, CFT1 and
CFT2 (Cryptococcus Fe Transporter), which are orthologs of S.
cerevisiae FTR1. Mutants lacking CFT1 and/or CFT2 were
constructed and characterized for their ability to use host
iron sources and to cause disease. We found that CFT1 is
involved in a reductive iron uptake pathway that is required
for utilization of transferrin. CFT1 is also required for full
virulence thus indicating that C. neoformans may preferentially
utilize transferrin in a tissue speciﬁc manner, especially in the
brain. CFT2 does not appear to play a role in iron acquisition
under the conditions we tested but did contribute to
virulence. We also demonstrate that CFT1 and CFT2 are
differentially regulated by Cir1 and that transcript levels of
both genes are inﬂuenced by the cAMP pathway.
Results
C. neoformans Possesses Two Orthologs of the S. cerevisiae
High-Affinity Iron Permease Ftr1
We initially searched the genome of the highly virulent
strain H99 (serotype A) of C. neoformans to identify orthologs
of the S. cerevisiae high-afﬁnity iron permease Ftr1 [8,34]. Two
highly conserved paralogous candidate genes were identiﬁed
and the gene on chromosome 12 was designated CFT1
(Cryptococcus Fe Transporter 1) while the gene on chromosome
3 was named CFT2. We had previously identiﬁed CFT1 (but
not CFT2) as a candidate iron permease gene in transcrip-
tional proﬁling experiments using serial analysis of gene
expression (SAGE) and microarrays to examine the response
to iron levels, cAMP signaling and experimental meningitis
[30,35,36]. In the study of Lian et al., (2005), disruption of
CFT1 in a serotype D strain background yielded a mutant
with poor growth on low iron medium. Interestingly, CFT2
was also found among genes with induced expression upon
phagocytosis [37].
A comparison of the predicted amino acid sequences
showed 36% identity and 54% similarity between Ftr1 of S.
cerevisiae and Cft1, 36% identity and 53% similarity between
Ftr1 and Cft2, and 53% identity and 66% similarity between
Cft1 and Cft2. Similarities in genome arrangements exist for
CFT1 and CFT2 in that CFT1 was paired with an adjacent
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Author Summary
Opportunistic fungal pathogens and other invading microbes must
overcome extreme iron limitation to proliferate in the mammalian
host. It is not yet known which iron sources are preferred by fungal
pathogens of mammals, although the mechanisms of acquisition are
beginning to be explored. Some fungi produce iron-chelating
siderophores to capture iron from host proteins, while others appear
to require a membrane-bound iron permease–ferroxidase system.
We describe the ability of the encapsulated yeast Cryptococcus
neoformans to use host iron sources including transferrin and heme,
and we identify an iron permease that is required for full disease
progression in experimental mouse models. The permease is
required for iron utilization from transferrin but not heme during
growth in laboratory culture. This result when combined with the
observed slow growth of the permease mutant during the
experimental infections implicates transferrin as an important iron
source in the host. However, we find that mutants lacking the
permease eventually do cause disease, thus revealing that additional
iron sources such as heme and other uptake mechanisms are
available to C. neoformans. Finally, we noted that the permease
mutant showed particularly poor growth in the brains of infected
animals, suggesting that transferrin may be an especially important
iron source in this tissue.putative ferroxidase gene designated CFO1 (Cryptococcus
Ferroxidase 1) and CFT2 was paired with the putative
ferroxidase gene CFO2. Both ferroxidases showed high
similarity to the Fet3 protein of S. cerevisiae (data not shown).
CFT1 and CFO1 are transcribed bi-directionally as are CFT2
and CFO2, with 791 bp and 2103 bp promoter regions,
respectively (Figure 1A). Measurements of basal transcript
levels of the genes under low-iron conditions (by RT-PCR)
showed that the transcripts of CFT1 and CFO1 were readily
detected whereas CFO2 was less abundant and CFT2 was
undetectable (Figure 1B). We focused on the roles and
regulation of CFT1 and CFT2 for this study.
Severance et al. (2004) showed that S. cerevisiae Ftr1 has
seven transmembrane domains with an orientation of N-
terminal outside and C-terminal inside the cell [38].
Furthermore, their study suggested that two motifs, REXLE
and DASE, are essential for iron transport and are strongly
conserved among other fungal Ftr1 homologs. In this context,
we analyzed the transmembrane (TM) helix number and TM
topology of Cft1 and Cft2 in silico with the protein
localization prediction program Localizome and found that
both proteins have seven predicted TM domains and the
same predicted topology as Ftr1 in S. cerevisiae [39]. Amino
acid alignments with the S. cerevisiae proteins Ftr1 and the
vacuolar iron transporter Fth1, and also with the C. albicans
Ftr1 and Ftr2 proteins, showed that both Cft1 and Cft2
possess the highly conserved motifs thought to be essential
for iron transport (Figure 1C).
Expression of CFT1 and CFT2 Is Iron Dependent and Is
Oppositely Regulated by Cir1
Transcript levels of the high-afﬁnity iron permease genes
are inﬂuenced by iron levels in S. cerevisiae, C. albicans and S.
pombe [12,22,25]. Therefore, we tested whether CFT1 and CFT2
are regulated in a similar manner in C. neoformans. Wild-type
cells were cultured in different concentrations of iron (0, 10,
100 and 1000 lM), and expression of CFT1 or CFT2 was
measured by real-time RT-PCR. Transcript levels of both
CFT1 and CFT2 were reduced as iron levels increased in
cultures of the wild-type strain (Figure 2). Therefore, it
appears that C. neoformans responds to iron deprivation by
increasing transcription of these candidate iron permease
genes. Note that although the transcript levels for CFT2 were
inﬂuenced by iron, the signiﬁcance for CFT2 function is
unclear because the basal transcriptional level of CFT2 in low
iron media was 100-fold lower than that of CFT1 (see also
Figure 1B). It may be that Cft2 has a minor or redundant
function in iron uptake relative to Cft1, that the gene plays a
role in other growth conditions, or that Cft2 functions to
transport iron from stores in the vacuole. Additionally, CFT1
and CFT2 transcript levels were reduced 10-fold and 3-fold
respectively in the wild-type strain during growth in 1000 lM
of iron, and this regulatory response may also suggest a minor
or different role for CFT2 in iron uptake.
We previously showed that iron permease genes are
downstream targets of the iron regulatory transcription
factor Cir1 in a C. neoformans serotype D strain by microarray
analysis. Northern analysis also suggested that CFT2 tran-
script levels were inﬂuenced by Cir1 in a serotype A strain
[26]. To further examine the regulation by Cir1, we
performed transcriptional analysis to determine whether
both CFT1 and CFT2 are downstream of Cir1 in the serotype
A strain. Transcription of CFT1 and CFT2 was monitored by
real-time RT-PCR in the cir1 mutant grown in media with
different concentrations of iron. Our results showed that
CFT1 transcript levels were reduced in the cir1 mutant,
indicating positive regulation by Cir1 (Figure 2). Further-
more, the CFT2 transcript was higher in the cir1 mutant
indicating negative regulation by Cir1 (Figure 2) and this
result is consistent with our previous observations [26]. In
addition, it appears that when Cir1 is deleted, the transcript
levels of CFT1 and CFT2 are no longer responsive to iron
concentrations compared with the wild-type strain.
Figure 1. Genomic Arrangement and Conserved Regions of CFT1 and
CFT2
(A) CFT1 and CFT2 are located on chromosomes 12 and 3, respectively.
The genes were disrupted by transforming the disruption cassette
containing the selectable marker for resistance to nourseothricin (NAT
r)
or neomycin (NEO
r) as shown.
(B) Basal levels of the transcripts are shown for the genes indicated
above the lanes. The cells were grown under low-iron conditions and
transcripts were amplified by RT-PCR (30 cycles).
(C) Comparison of specific regions of the predicted amino acid
sequences of Cft1 and Cft2 with the high-affinity iron permeases in
other fungi. Both Cft1 and Cft2 contain the highly conserved motifs
underlined. CnCft1: C. neoformans Cft1 from strain H99; CnCft2:
C. neoformans Cft2 from strain H99; CaFtr1: C. albicans CaFtr1
(AAF69680); CaFtr2: C. albicans CaFtr2 (AAF69681); ScFtr1: S. cerevisiae
Ftr1 (NP_011072); ScFth1: S. cerevisiae Fth1 (CAA85171).
doi:10.1371/journal.ppat.0040045.g001
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Iron Permease in C. neoformansCFT1 Is Necessary for Growth on Iron Sources that Require
Reductive Uptake
To characterize the functions of CFT1 and CFT2,w e
generated mutants lacking each of the genes. Double mutants
lacking both genes were also constructed to potentially
unmask phenotypes hidden by redundancy (see Materials
and Methods). Reconstituted strains with a reintroduced wild-
type copy of CFT1 or CFT2 at the original locus were also
constructed and analyzed. Initial tests indicated that several
independently generated cft1 and cft2 mutants showed similar
growth rates in YPD medium at 308C. These tests also revealed
that the mutants did not differ from wild type with regard to
capsule formation in low iron medium, melanin synthesis and
growth at 378C. The cft1 cft2 double mutants also did not
display changes in capsule or melanin production, but did
display a reduced growth rate in YPD medium (Figure S1).
The wild-type strain, each single mutant and the recon-
stituted strains were tested for utilization of different iron
sources in vitro. Strains were ﬁrst grown in low-iron medium
to reduce intracellular iron stores, and then were transferred
to fresh low-iron medium and low-iron medium supple-
mented with the inorganic iron salt FeCl3, apo-transferrin,
holo-transferrin, heme or siderophores. Transferrin and
heme were of particular interest because of their abundance
Figure 2. Expression of CFT1 and CFT2 Is Iron Dependent and Differentially Regulated by Cir1
Transcriptional regulation of CFT1 and CFT2 in the wild-type strain and the cir1 mutant was monitored by quantitative real-time RT-PCR after growing
cells in medium containing various concentrations of iron (0, 10, 100 and 1,000 lM of FeCl3). Data were normalized by using ACT1 as an internal control
and are presented as relative expression. Data are from four replicates and bars represent the standard deviations.
doi:10.1371/journal.ppat.0040045.g002
Figure 3. CFT1 Is Required for Reductive Iron Uptake
(A) Iron-starved strains (the wild-type, the cft1 mutant and the CFT1 reconstituted strain) were inoculated into media containing FeCl3, apo-transferrin or
holo-transferrin, which were added in stepwise 2-fold dilutions. The actual range of concentrations in the cultures was between 200 lM and 0.78 lMo f
FeCl3, and 20 lM and 0.078 lM of apo- or holo-transferrin. The OD620 reading at 0.1 lM in FeCl3 containing plates and 0.01 lM in Apo- or Holo-
transferrin containing plates represent the level of growth in media without an added iron source, starting at the standard inoculum density of 0.08. All
cultures were incubated at 308C and turbidity was measured after 72 h. The averages of three independent experiments are presented with bars
representing the standard deviations.
(B) The same experiments as shown in (A) were performed for the cft2 mutant and all strains showed similar patterns of growth.
doi:10.1371/journal.ppat.0040045.g003
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Iron Permease in C. neoformansas iron sources in mammals. The different concentrations of
iron sources were prepared by serial dilution to ensure that
any growth phenotypes observed could be correlated to a
dependence on the iron source. The wild-type strain grew
well with all iron sources and showed particularly robust
growth in the presence of the iron-loaded siderophore,
feroxamine (Figures 3 and 4). As expected, little or no growth
was observed with apo-transferrin and the siderophore
deferoxamine that lacks iron. The cft2 mutants behaved like
the wild-type strain in all conditions (Figures 3B and 4B). In
contrast, the cft1 mutants showed reduced growth in the
presence of inorganic iron (FeCl3) or holo-transferrin, but
not heme or feroxamine (Figures 3A and 4A). Moreover, the
cft1 mutant displayed growth defects for all concentrations of
FeCl3 or holo-transferrin, a result consistent with the idea
that Cft1 may be a high-afﬁnity iron permease in C.
neoformans. An analysis of the time course of growth for the
strains also conﬁrmed the growth defect of the cft1 mutant
with FeCl3 as the iron source, and demonstrated that the cft1
cft2 double mutant behaved like the cft1 mutant in this assay
(Figure S2A). These ﬁndings suggest that CFT1 is required for
the reductive iron uptake pathway in C. neoformans because
ferric iron and iron from transferrin are believed to be
transported via this pathway. Given that transferrin is a major
iron carrier in the mammalian host, CFT1 may play a key role
for iron acquisition during infection. These results also
indicate that uptake of siderophore-bound iron is independ-
ent of CFT1 and CFT2.
A cft1 Mutant Is Attenuated for Iron Uptake from FeCl3
and Transferrin
The ability of the wild-type and mutant strains to take up
iron was directly compared by assaying accumulation of iron
from
55FeCl3 and from
55Fe-loaded transferrin (Figure 5). In
the assay with
55FeCl3, iron uptake by the cft1 mutant and the
cft1 cft2 double mutant occurred at only 27% and 11% of the
level found for the wild-type strain, respectively, suggesting
that Cft1 plays a primary role in iron uptake in C. neoformans
(Figure 5A). Although Cft2 appeared to make a contribution
based on the lower uptake of the double mutant, the cft2
mutant did not show a statistically signiﬁcant reduction in
uptake compared to the wild-type strain. Cft1 also played a
major role in the acquisition of
55Fe from transferrin because
negligible uptake was detected compared with the wild-type
or reconstituted strains (Figure 5B). The cft1 cft2 double
mutant again behaved like the cft1 mutant and no inﬂuence
on uptake was seen in the strain lacking CFT2. Overall, these
results highlight the role of Cft1 in iron uptake and are
consistent with the poor growth of the cft1 mutant on iron
sources that require reductive uptake.
Loss of CFT1 Influences Transcript Levels for CFT2 and the
Siderophore Transporter Gene SIT1
Loss of the high afﬁnity iron uptake system would be
expected to cause lower intracellular iron availability and to
potentially inﬂuence the expression of iron-responsive genes.
In addition, studies in S. cerevisiae indicate that modifying the
Figure 4. Non-Reductive Iron Uptake Systems Are Independent of Cft1 and Cft2
(A) Iron-starved strains (the wild-type, the cft1 mutant and the CFT1 reconstituted strain) were inoculated into media containing heme, deferoxamine
and feroxamine, which were added in stepwise 2-fold dilutions. The range of concentrations was between 20 lM and 0.78 lM (heme) and between 10
lM and 0.78 lM (deferoxamine and feroxamine); note that the scale on the X-axis is between 0.01 and 10 or 100 lM. In each graph, the OD620 reading
at 0.01 lM indicates the level of growth in media without an added iron source starting at the standard inoculum density of 0.08. All cultures were
incubated at 308C and turbidity was measured after 72 h. Averages of three independent experiments are presented with bars representing the
standard deviations.
(B) The same experiments as shown in (A) were performed for the cft2 mutant and all strains showed similar patterns of growth.
doi:10.1371/journal.ppat.0040045.g004
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Iron Permease in C. neoformansexpression of Fet4, which is responsible for low-afﬁnity iron
uptake, can modulate expression of components of the high-
afﬁnity iron uptake system. Speciﬁcally, disruption of FET4
increases the activity of the high afﬁnity uptake system and
overexpression of FET4 decreases the activity [40]. In light of
these observations, we investigated transcript levels for CFT1
in the cft2 mutant and for CFT2 in the cft1 mutant. We also
analyzed levels of the SIT1 transcript in the cft1 and cft2
mutants to determine whether alteration of the reductive
iron uptake pathway inﬂuenced the non-reductive side-
rophore uptake pathway.
The wild-type strain and the cft1 and cft2 mutants were
grown in media containing different concentrations of iron
and the transcript levels of CFT1, CFT2 and SIT1 were
measured by real-time RT-PCR. We found that the transcript
levels of CFT1 displayed similar and expected expression
patterns in both the wild-type strain and the cft2 mutant;
speciﬁcally, mRNA levels of CFT1 decreased as the iron
concentration increased (Figure 6A). In contrast, CFT2
transcript levels were elevated in the cft1 mutant, especially
in the presence of 10 lM and 100 lM iron, compared to the
reduced levels seen in the wild-type strain in response to iron
(Figure 6B). This result supports the conclusion that loss of
Cft1 leads to reduced intracellular iron levels. It is possible
that the elevated CFT2 transcript levels resulting from loss of
CFT1 could potentially result in more Cft2 product and
inﬂuence the iron acquisition capabilities of the cells.
Figure 5. Iron Uptake Is Impaired in the cft1 Mutant
(A) Strains were grown in defined low-iron medium and analyzed for iron
uptake with
55FeCl3. The results show the average from three experi-
ments with bars representing the standard deviations. The asterisk (*)
indicates that the iron uptake for the cft1 cft2 double mutant was
statistically different from that of the cft1 mutants (p ¼ 0.007 by a
Student t test).
(B) The strains indicated were grown in low-iron medium and uptake of
55Fe from transferrin was measured. The results shown are an average
from three experiments with bars representing the standard deviations.
doi:10.1371/journal.ppat.0040045.g005
Figure 6. CFT1 Influences Transcript Levels for CFT2 and the Siderophore
Transporter Gene SIT1
(A) Transcriptional regulation of CFT1 in the cft2 mutant was monitored
by quantitative real-time RT-PCR after growing cells in media containing
different concentrations of iron (0, 10, 100 and 1,000 lM of FeCl3).
(B) Transcriptional regulation of CFT2 in the cft1 mutant was monitored
by quantitative real-time RT-PCR in the same culture conditions.
(C) Transcription of SIT1 was analyzed in both the cft1 and the cft2
mutant strains in parallel experiments. All data were normalized by using
ACT1 as an internal control, according to the DDCt method, and are
presented as fold changes (y-axis). Data are from four replicates and bars
represent the standard deviations.
doi:10.1371/journal.ppat.0040045.g006
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Iron Permease in C. neoformansFor the SIT1 gene, both the wild-type strain and the cft2
mutant showed an iron-dependent reduction of SIT1 tran-
script levels (Figure 6C). However, SIT1 levels were higher in
the cft1 mutant compared to other strains, and the levels were
no longer entirely responsive to environmental iron concen-
tration. These results again imply that the cft1 mutant is
debilitated in its ability to import iron and that intracellular
iron levels may become constitutively low. This situation
would potentially account for the unresponsive expression of
SIT1 even in the presence of 1000 lM of iron. This is in
contrast to the decrease in the CFT2 transcript at the same
iron concentration and this difference may reﬂect distinct
mechanisms of iron regulation for the two genes. As
mentioned above, CFT2 is negatively regulated by the iron-
responsive transcription factor Cir1 and we have shown
previously that SIT1 is positively regulated [26]. Overall, our
results suggest that disruption of CFT1 inﬂuences expression
of CFT2 and SIT1, a result that is consistent with a reduction
in intracellular iron levels in the cft1 mutant.
Regulation of CFT1 and CFT2 by PKA
The cAMP pathway controls the expression of high-afﬁnity
iron permeases in S. cerevisiae and U. maydis. However, these
two fungi display opposite regulatory patterns. In S. cerevisiae,
expression of the gene for the high-afﬁnity iron permease,
FTR1, is negatively regulated whereas in U. maydis, expression
of the orthologous gene, FER2, is positively regulated [24,27].
These observations led us to investigate regulatory mecha-
nisms of the high-afﬁnity iron permease genes CFT1 and
CFT2 in relation to the cAMP pathway in C. neoformans. For
this analysis, strains lacking the genes encoding the catalytic
subunits (PKA1, PKA2) or the regulatory subunit (PKR1)o f
PKA were grown in media containing different concentra-
tions of iron, and transcript levels of CFT1 and CFT2 were
compared by real-time RT-PCR. The results revealed a similar
expression pattern for CFT1 in the wild-type strain and the
pka1 and pka2 mutants such that the transcript level was
dependent on iron concentration. However, CFT1 expression
was found to be reduced by 2- to 3-fold in the pkr1 mutant
compared to the wild-type strain (Figure 7A). Conversely, the
transcript levels of CFT2 were found to be elevated upon
deletion of PKA1 (Figure 7B). These results indicate that the
cAMP pathway negatively regulates the transcript level of
CFT2 via Pka1 in C. neoformans and suggest that PKA also
negatively inﬂuences CFT1 expression but to a lesser extent.
As mentioned earlier, the basal transcript level for CFT2 is
much lower than that of CFT1 and this may inﬂuence both
the detection and the biological relevance of PKA regulation
of these genes. It is interesting, however, that the loss of
different subunits of PKA inﬂuences transcript levels for the
two genes, and that reciprocal patterns of regulation for loss
of the catalytic and regulatory subunits were not observed.
These results suggest that the inﬂuence of the cAMP pathway
may be exerted by different mechanisms for each of the
genes.
The cft1 Mutant Has Increased Susceptibility to Inhibitors
of Fungal Sterol Metabolism
A relationship between iron levels and susceptibility to
antifungal drugs that act at the level of ergosterol biosyn-
thesis has been reported [41]. Speciﬁcally, the availability of
iron inﬂuences susceptibility of C. albicans to antifungal drugs,
and strains lacking the iron permease CaFtr1 display
increased sensitivity to ﬂuconazole due to alteration of
expression of genes in the ergosterol synthesis pathway [41].
A similar connection also exists in S. cerevisiae because
cytosolic iron levels inﬂuence C-4 methyl sterol oxidase
(Erg25), an enzyme that is essential for ergosterol synthesis
[42]. In this context, we tested the C. neoformans iron permease
mutants to investigate whether a deﬁciency in iron uptake
alters susceptibility to antifungal drugs. The cft1 mutant
displayed increased sensitivity to the azole, miconazole,
suggesting that a deﬁciency in iron uptake may also inﬂuence
ergosterol synthesis in C. neoformans (Figure 8). This pheno-
type is also supported by the observation that cft1 mutants
showed an increase in sensitivity to the antifungal drug
amphotericin B, compared to the wild-type strain (Figure 8).
These ﬁndings suggest that inhibitors of Cft1 activity could
provide a synergistic effect when used in combination with
existing antifungal drugs, and that Cft1 could be a novel drug
target for treatment of cryptococcosis.
The cft1 Mutant Is Attenuated for Virulence and for
Colonization of the Brain
The deﬁciency of the cft1 mutant in growth and iron
acquisition with transferrin prompted an examination of the
virulence of the cft1 and cft2 mutants in the mouse inhalation
model of cryptococcosis. We found that mice infected with
the wild-type strain, the cft2 mutant, and the CFT1 or the
CFT2 reconstituted strains, showed 100% mortality by ;20
Figure 7. The Expression of CFT1 and CFT2 Are Regulated by
Components of the cAMP-Dependent Protein Kinase
Strains lacking PKA1, PKA2 or PKR1 were grown in media containing
different concentrations of iron (0, 10, 100 and 1,000 lM of FeCl3), and
transcript levels of CFT1 (A) or CFT2 (B) were compared by quantitative
real-time RT-PCR. Data were normalized by using ACT1 as an internal
control, according to the DDCt method, and presented as relative
expression. Data are from four replicates and bars represent the standard
deviations.
doi:10.1371/journal.ppat.0040045.g007
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;43 days indicating that deletion of CFT1 caused a signiﬁcant
attenuation of virulence (Figure 9A). These results support
the conclusion that Cft1 plays a role in iron acquisition in
vivo. Furthermore, because the cft1 mutants showed defects in
transferrin but not in heme and siderophore utilization in
vitro, we hypothesize that transferrin is an important iron
source for C. neoformans during growth in mammalian hosts.
The virulence attributes of the cft1 single and the cft1 cft2
double mutants were also compared in a separate experi-
ment. We found that mice infected with the double mutant
survived to ;54 days, a time signiﬁcantly longer than mice
infected with the cft1 single mutants (Figure 9B). These results
suggest that Cft2 makes a contribution during infection that
is evident in the absence of CFT1.
The distribution of fungal cells in the infected mice was
also assessed to determine the ability of the cft1 mutant to
colonize host tissue. Organs from mice infected with the wild-
type strain, the cft1 mutant or the CFT1 reconstituted strain
were collected and fungal burden was measured by determin-
ing colony-forming units (CFU). We harvested the organs at
days 19 and 34 because mice infected with the wild-type and
reconstituted strains succumbed to infection on or around
day 19 and mice infected with the cft1 mutant started to reach
the endpoint at approximately day 34. These time points for
the inhalation model of cryptococcosis would therefore
represent the maximum disease progression in terms of
fungal dissemination and proliferation. As shown in Figure
10A, wild-type and reconstituted cells were widely dissemi-
nated throughout the host at day 19. However, in mice
infected with the cft1 mutant, the number of the fungal cells
was much lower at day 19 suggesting a defect in dissemination
and/or colonization of organs (Figure 10A). We hypothesize
that the failure of the cft1 mutant to disseminate or colonize
during infection is due, at least in part, to an inability to use
transferrin. The cft1 mutant eventually disseminated from the
lung to the spleen and the liver in infected mice by day 34
(Figure 10A), implying that the cft1 mutants can presumably
utilize host iron sources other than transferrin (e.g., heme). In
particular, the fungal burdens for the cft1 mutant were higher
at day 34 in the lung, spleen and liver (30-, 17- and 21-fold,
respectively) compared to day 19. However, the number of
fungal cells in the brains of mice infected with the cft1 mutant
remained low and was only two-fold higher at day 34
compared to day 19 (Figure 10A). This observation implies
that transferrin or similar iron sources transported by CFT1
via the reductive iron uptake pathway may be primary iron
sources for C. neoformans in the brain. It is likely that the cft1
and the cft1 cft2 mutants can use other iron sources in
infected mice, and heme is a likely candidate because these
mutants grow well with heme as the sole iron source in vitro
(Figures 4A and S2).
We also tested whether a different route of inoculation of
fungal cells by tail vein injection could inﬂuence the behavior
of the cft1 mutant in vivo. Mice infected with the wild-type
and the CFT1 reconstituted strains succumbed within 7 days.
In contrast, mice infected with the cft1 mutant survived to day
;29 (data not shown) thus revealing that the cft1 mutant was
also attenuated for virulence in this model of cryptococcosis.
In general, approximately three orders of magnitude more
fungal cells were found in the brains of the mice infected via
tail vein injection than via inhalation. For this experiment, we
chose to compare fungal burden at the time of illness for the
mice infected with the different strains. Speciﬁcally, organs
from mice infected with the wild-type strain or the CFT1
reconstituted strain were collected at day 7, and organs from
mice infected with the cft1 mutant were harvested at day 29.
Similar to results from inhalation model, lower numbers of
the cft1 mutant cells were found in the brain, the spleen and
the liver when the mice became ill at day 29 compared to
infection with the wild-type strain at day 7 (Figure 10B). The
result for the lung was a notable exception in that higher
numbers of cft1 mutant cells were found in mice infected with
the cft1 mutant at day 29 (Figure 10B), a phenomenon that
was also observed in the inhalation model. We further
Figure 8. Deletion of CFT1 Increases Susceptibility to Antifungal Agents
that Target Fungal Sterol Biosynthesis and Function
The growth of strains in media containing the antifungal drugs
miconazole and amphotericin B was monitored to assess sensitivity.
Ten-fold serial dilutions of cells (starting at 10
6 cells) were spotted onto
YPD plates with and without the antifungal drug indicated. Plates were
incubated at 308C for two days.
doi:10.1371/journal.ppat.0040045.g008
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the brain or lungs compared to the wild-type strain in a
three-day time course after tail vein injection (Figure 10C).
Overall, these data suggested that CFT1 makes a contribution
to virulence during cryptococcosis, and that transferrin or
other iron sources dependent on Cft1 could potentially be
primary sources for C. neoformans within the host, especially in
the brain.
Discussion
Iron uptake and homeostasis functions are known to be
important for the pathogenesis of C. neoformans because iron
overload exacerbates experimental cryptococcosis and iron
levels inﬂuence the expression of virulence factors [26,36,43].
Pioneering physiological studies indicate that C. neoformans
possesses at least two iron uptake systems [31,32,44]. The ﬁrst
is the utilization of siderophores although the fungus does
not appear to produce these molecules [31]. The other is a
reductive iron uptake system in which ferric iron is reduced
to the ferrous form by cell surface reductase activity, by
secreted reductants and by melanin in the cell wall [32,44].
Jacobson et al. (1998) detected activities of both high- and low-
afﬁnity iron uptake systems from cell cultures of C. neoformans,
estimated the Km of the high-afﬁnity uptake to be 0.6 lM and
found that the activity of the high iron uptake system is
down-regulated by 15 lM of iron [31]. The low-afﬁnity uptake
system has not been characterized. In the context of these
ﬁndings, we determined the roles of the CFT1 and CFT2 genes
that show sequence similarity to genes for the iron permeases
responsible for high-afﬁnity iron uptake in other fungi such
as S. cerevisiae and C. albicans. Our analysis of mutants defective
in CFT1, CFT2 or both genes revealed that CFT1 plays the
major role in iron acquisition in C. neoformans. The cft1
mutant displayed growth defects in the presence of iron
sources (FeCl3 and transferrin) that are known to be trans-
ported by reductive iron uptake system in C. albicans [13].
These results, together with our expression data showing that
CFT1 is down-regulated at higher iron concentrations,
suggest that Cft1 functions as a high-afﬁnity iron permease
responsible for iron uptake in C. neoformans. However, Cft1 is
not involved in the heme or siderophore uptake systems in
C. neoformans because we found that the cft1 mutant displays
normal growth with these iron sources.
The role of Cft2 in C. neoformans is less clear because of the
low transcript level for the gene and the lack of robust
phenotypes for the cft2 mutant. Several lines of evidence
suggest that Cft2 may play a minor role and may function
redundantly with Cft1. First, the cft1 cft2 double mutants
displayed a growth defect in the rich medium YPD (an iron-
replete condition), whereas the cft1 and cft2 single mutants
did not show growth defects in this medium. Second, the
expression of CFT2 is up-regulated in the cft1 mutants and in
response to iron limitation. Finally, the cft1 cft2 mutant
showed attenuated virulence compared with the single cft1
mutant. It is possible that CFT2 encodes a low afﬁnity iron
permease or, alternatively, that it encodes a vacuolar
permease that functions to transport stored iron to the
cytoplasm. It is also possible that the expression of CFT2 may
be different (e.g., higher), and that the gene may make a
contribution, under conditions not tested in our study.
Further biochemical analyses and localization studies will be
needed to better deﬁne the role of Cft2.
The presence of two candidate iron permease genes, CFT1
and CFT2,i nC. neoformans is, at ﬁrst glance, similar to the
situation in C. albicans where the iron permease genes CaFTR1
and CaFTR2 have been characterized [12]. As was found with
CaFTR1, CFT1 appears to play a major role in iron uptake,
growth on speciﬁc iron sources and virulence. A mutant
lacking CaFTR2 is similar to the cft2 mutant in that neither
showed growth phenotypes and neither is required for
virulence. However, the regulation of CaFTR2 is quite
different because it has a low transcript level in low iron
conditions and an elevated transcript at higher levels.
Ramanan and Wang [12] suggest that the differential
expression of CaFTR1 and CaFTR2 may reﬂect their functions
in different environments. Similarly, CFT2 may be expressed
under speciﬁc conditions and, in this context, it is interesting
that Fan et al. [37] found that CFT2 and CFO2 transcript levels
were induced upon phagocytosis. Thus, these genes may make
a contribution during infection consistent with the observed
additional attenuation in virulence found for the cft1 cft2
mutant compared with the cft1 mutant.
Previously, we described the role of the GATA type zinc
ﬁnger transcription factor Cir1 in iron-related regulation in
C. neoformans [26]. Microarray analysis revealed that Cir1
regulates expression of genes required for iron uptake in
both a negative and a positive manner [26]. In that report, we
found that a putative iron permease (XP_569788) is a
negatively regulated, downstream target of Cir1 in the
Figure 9. The cft1 and cft1 cft2 Mutants Are Attenuated for Virulence
(A) Ten female A/Jcr mice were infected intranasally with each of the
strains indicated and the survival of the mice was monitored over the
time course indicated on the x-axis. The difference in survival between
the cft1D mutant and the WT strain was significant based on a Kaplan-
Meier survival analysis (p , 0.0001).
(B) In a separate experiment, the virulence of the cft1D cft2D double
mutant was compared with that of the WT strain and the cft1D mutant,
again with 10 mice per inoculation. A second, independently isolated,
double mutant showed a similar attenuation of virulence. All of the
virulence tests were performed at least twice. The difference in survival
between the cft1D mutant and the WT strain was significant (p ,
0.0001), as was the difference between the cft1D mutant and the cft1D
cft2D double mutant (p , 0.0001).
doi:10.1371/journal.ppat.0040045.g009
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Iron Permease in C. neoformansFigure 10. The cft1 Mutant Shows Reduced Tissue Colonization in a Mouse Model of Cryptococcosis
(A) Distribution of fungal cells in the organs of mice infected by the inhalation method. Organs from mice infected with the wild-type strain, the cft1
mutant or the CFT1 reconstituted strain were collected at day 19 when the wild type and the reconstituted strain reached the end point. Additionally,
organs from mice infected with the cft1 mutants were collected at day 34 when mice reached the end point. Fungal burdens were monitored in organs
by determining colony-forming units (CFU) upon plating on YPD medium. Three mice for each strain were used at each time point. Data are average
CFUs per organ with standard deviations. CFUs for the cft1 mutant at day 34 are marked with an asterisk; the other counts are from day 19.
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Iron Permease in C. neoformansserotype D strain B3501A. The current study revealed that
this gene is equivalent to CFT2 in the serotype A strain H99.
We also identiﬁed another iron permease gene (XP_568258)
from the microarray experiments that we now know
corresponds to CFT1. We should note that values represent-
ing differential expression of the CFT1 ortholog
(XP_568258) were not statistically signiﬁcant in the micro-
array analysis in the serotype D strain background. The
current study using a serotype A strain revealed that CFT1 is a
positively-regulated downstream target gene of Cir1, which is
opposite to the regulation found for CFT2. This conﬁrms our
previous ﬁndings of a dual mode of Cir1 regulation in
C. neoformans [26]. The SIT1 gene, which encodes the
siderophore transporter [33], also belongs in the regulatory
network of genes positively controlled by Cir1.
As mentioned, the cAMP pathway negatively regulates
genes involved in the high afﬁnity iron uptake through the
protein kinase A subunit Tpk2 in S. cerevisiae. U. maydis also
possesses similar connections but the pathway positively
regulates genes involved in the high afﬁnity uptake [24]. In
our study, we observed that the cAMP pathway regulates
transcriptional levels of iron permease genes in C. neoformans.
An ;2-fold reduction in CFT1 transcript levels was found in
the pkr1 mutant and a marked elevation of the CFT2
transcript was found in the pka1 mutant (;10-fold). These
data suggest that regulation of CFT1 by the cAMP pathway
may be indirect and of minor signiﬁcance under the
conditions we tested. Also, the pka1 mutant did not show a
reciprocal pattern of differential expression compared with
the pkr1 mutant in terms of CFT1 transcript levels, again
suggesting that the inﬂuence may be indirect. The more
substantial regulation of CFT2 by Pka1 further supports the
idea that there may be speciﬁc conditions where Cft2 makes a
contribution to iron acquisition or other functions. The
reason why Pka1 controls CFT2, but not CFT1, remains to be
investigated. Finally, the regulation by cAMP extends to other
genes involved in iron acquisition in C. neoformans because we
previously found elevated transcripts for the SIT1 gene
(siderophore transporter) in the pka1 mutant [33].
The expression of the CFT1 and CFO1 genes was recently
shown to be inﬂuenced by deletion of the regulatory gene
SRE1, which functions in an oxygen sensing pathway in C.
neoformans [45]. Based on predictions from work on Sre1 in S.
pombe, Chang et al. [45] found that Sre1 in a serotype D strain
of C. neoformans is activated by inhibition of sterol synthesis
and low oxygen levels, and that the gene is required for wild-
type levels of growth under hypoxic and low iron conditions.
A microarray experiment to compare the transcriptomes of
wild type and sre1 mutant cells grown in a low oxygen
environment revealed that Sre1 positively inﬂuences the
expression of ;100 genes. These genes encoded enzymes for
ergosterol biosynthesis as well as iron transport functions
such as Cft1 and Sit1 [33], and the copper transporter Ctr4
[46]. Deletion of SRE1 negatively inﬂuenced the expression of
another 414 genes and many of these encoded stress-related
functions. The role of the SRE1 gene has also been
characterized in a serotype A strain of C. neoformans [47]. In
this strain background, the sre1 mutant displays a hypoxia-
sensitive phenotype, slight defects in capsule and melanin
formation, and a reduced ability to proliferate and cause
disease in a mouse model of infection. Interesting, Chun et al.
[47] did not observe the changes in transcript levels for the
CFT1 and CFO1 genes as a result of hypoxia or loss of SRE1
that were seen by Chang et al. [45]. This may reﬂect
differences in the regulation of iron uptake functions
between strains of the A and D serotypes.
The connections between oxygen, iron and sterol biosyn-
thesis established by Chang et al. [45] are interesting in light
of our ﬁnding that the cft1 mutant displayed increased
sensitivity to an inhibitor of ergosterol biosynthesis. This
observation further supports the idea that C. neoformans,a sa
strict aerobe, must balance iron availability with oxygen levels
and ergosterol synthesis [26,45]. Similar connections have
been described in S. cerevisiae, although this fungus is capable
of anaerobic growth. In yeast, anaerobiosis results in reduced
heme synthesis, a lower rate of synthesis of respiratory
proteins and loss of the ability to synthesize sterols because of
the iron dependence of enzymes in the pathway [48].
SRE1 in C. neoformans is also required for the establishment
and growth of the fungus in the brains of infected mice thus
indicating that this tissue site may be limited for oxygen, and
perhaps for iron. Our ﬁnding that the cft1 mutant has
reduced colonization of the brain further suggests that this
tissue is limited for iron. Additional evidence for integration
of iron, oxygen and sterol biosynthesis comes from the
ﬁnding that a 2.2-fold reduction was seen for SRE1 transcript
levels under the iron limited condition in the cir1 mutant
[26,45]. Thus, SRE1 may be a direct or indirect target of Cir1
regulation and the two regulators could also potentially
interact at the promoters of genes such as CFT1. Additionally,
these factors both inﬂuence the transcript levels of the
copper transporter Ctr4. Waterman et al. [46] showed that
this gene is activated by the transcription factor Cuf1 and, in
parallel with the ﬁndings for the sre1 and cft1 mutants, cuf1
mutants show reduced CNS colonization in a murine model
of infection. Overall, these results provide the ﬁrst glimpses
of the integration of oxygen, sterol, copper and iron sensing
regulatory schemes that inﬂuence virulence and CNS
colonization in C. neoformans.
Our analysis revealed that the cft1 mutant (but not the cft2
mutant) showed reduced virulence in the mouse model of the
cryptococcosis, a result consistent with a role for Cft1 in iron
acquisition in vivo. This is consistent with SAGE experiments
on C. neoformans cells from a rabbit model of cryptococcal
meningitis and from a mouse pulmonary infection which
show that CFT1 transcript was abundant during growth in the
host [35] (Hu and Kronstad, manuscript in preparation).
CFT2 appears to make a minor contribution because the cft1
cft2 double mutant showed a further reduction in virulence
compared to the cft1 mutant. Two models of cryptococcosis
(B) Distribution of fungal cells in mice infected by the tail vein injection method. Organs from mice infected with the wild-type strain or the CFT1
reconstituted strain were collected at day 7 when the wild type and the reconstituted strain reached the end point. Organs from mice infected with the
cft1 mutants were collected at day 29 when mice reached the end point. Fungal burdens were monitored as described in (A). Three mice for each strain
were used. Data are averages with standard deviations. CFUs for the cft1 mutants at day 29 are marked with an asterisk; the other counts are from day 7.
(C) The ability of the cft1 mutant to colonize brain and lung tissue was compared with the wild-type strain. Mice were inoculated with 2.5310
5 cells by
tail vein injection, sacrificed at the times indicated and analyzed for fungal burden.
doi:10.1371/journal.ppat.0040045.g010
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of fungal cells in the brains, spleens and livers of mice
infected with the cft1 mutant compared to mice infected with
the wild-type and reconstituted strains. Overall, it appeared
that the mutant exhibited a generalized growth defect that
could account for the slower disease progression. In
particular, we noted a delayed appearance of the fungal cells
in brains of mice infected with the cft1 mutants by either
route. The cft1 mutant cells did eventually reach high levels in
the lungs near the time that the mice succumbed to infection.
The higher burden was particularly striking compared with
the low numbers in the brain at the same time. This
observation may indicate that lung tissue provides a growth
environment in which the requirement for Cft1 is not as
stringent as in the brain. For example, tissue differences in
oxygen availability may inﬂuence the requirement of the
fungus for iron [49].
The delayed disease progression for the cft1 and the cft1 cft2
mutants supports our hypothesis that C. neoformans is partially
dependent on an iron source that requires a reductive uptake
system during infection. Transferrin is likely the source
because of its abundance and because the cft1 mutant showed
defects in the utilization and uptake of iron from transferrin
in vitro. We hypothesize that transferrin may be particularly
important for the growth of C. neoformans in the brain.
Transferrin may be the primary iron source in the CNS
because it is the only iron carrier protein that can be
transported through the blood-brain barrier (BBB) [50].
Although a reduction in fungal burden in mice infected with
the cft1 mutant was apparent, the mutant eventually caused
mortality. We propose that the cft1 mutant (and the cft1 cft2
mutant) was able to grow in the host because it could also
u t i l i z ei r o ns o u r c e ss u c ha sh e m ev i aan o n - r e d u c t i v e
mechanism. This idea is consistent with our ﬁnding that
wild-type cells showed robust growth in the presence of heme
or siderophores. The mechanisms of heme utilization have
not been investigated in C. neoformans.
C. neoformans must breach the BBB and invade the CNS to
cause meningoencephalitis. Only a few pathogenic microbes
are able to cross the BBB and the process is best understood
in bacteria. For example, the bacterium Listeria monocytogenes
infects leukocytes and is then transported into the CNS
during leukocyte migration through the BBB (i.e., the ‘‘Trojan
horse’’ mechanism) [51]. The encapsulated bacteria Strepto-
coccus pneumoniae and Neisseria. meningitis use transcytosis to
cross a monolayer of brain endothelial cells [52,53]. Evidence
to date indicates that C. neoformans is also able to adhere to
and transcytose across human brain microvascular endothe-
lial cells [54]. In this context, we speculate that CFT1 may play
an iron acquisition role while the fungus is within the
endothelial cell during transcytosis and/or while the fungus is
within CNS. Interestingly, holo-transferrin also enters the
endothelial cells of the BBB by transcytosis so this iron source
would potentially be available to the fungus [55]. The
mechanisms of iron acquisition by C. neoformans during
phagocytosis by macrophages also remains to be investigated.
As mentioned, CFT2 transcripts are elevated upon phagocy-
tosis but we note that recent studies show that phagosome
extrusion of the fungal cells occurs as early as 2 hours after
uptake [56,57]. Overall, our results provide insights into the
role of iron acquisition functions in cryptococcal disease,
reveal iron source preferences, and suggest possible targets
for antifungal therapy, especially in the context of treating
fungal meningitis.
Materials and Methods
Strains and growth conditions. The strains used in this study (Table
S1) were routinely grown in yeast extract, bacto-peptone medium
with 2.0% glucose (YPD, Difco) or yeast nitrogen base (YNB, Difco)
with 2.0% glucose. Deﬁned low iron medium was prepared as
described [58] and we have determined that this medium contains
approximately 1.3 lM iron (data not shown). This medium was used
for the experiments described in Figures 2–4, 6, and 7, and 0 lMi n
the ﬁgure labels indicates that no additional iron was added. Iron-
replete medium was prepared by adding the iron sources FeCl3, holo-
transferrin, heme or feroxamine into low-iron medium at the ﬁnal
concentrations indicated in the text. To assess growth, cells were ﬁrst
grown in low-iron medium for two days at 308Ct od e p l e t e
intracellular iron stores and to fully induce the high afﬁnity iron
uptake system in C. neoformans, as suggested by Jacobson et al. [31].
The number of cells was determined using a haemocytometer and 2.0
310
4 cells were transferred to the wells of a 96-well plate containing
low-iron medium as a control or low-iron medium containing
different iron sources. Iron sources were diluted by serial two-fold
dilutions in a total volume of 200 ll. The plates were incubated at
308C for three days, and the optical density of each well was read with
a microtitre plate reader at 595 nm. Additional experiments to
examine growth rate were performed in 5 ml cultures containing low
iron medium supplemented with the same iron sources. For
antifungal sensitivity tests on plates, 10-fold serial dilutions of cells
were spotted onto YPD plates containing miconazole or amphoter-
icin B. Plates were incubated at 308C for two days.
Construction of mutant strains. The locus numbers for CFT1 and
CFT2 in the C. neoformans serotype A genome are CNAG_06242.1
and CNAG_02959.1, respectively (http://www.broad.mit.edu/
annotation/genome/cryptococcus_neoformans). The sequences for
these genes were used for mutant construction. All primers used for
the experiments are listed in Table S2. To construct a cft1 mutant, the
genomic region of 1740 bp that corresponds to the entire coding
sequence of CFT1 was replaced by a disruption cassette containing
the nourseothricin acetyltransferase gene (NAT) using 5’ and 3’
ﬂanking sequences of CFT1. The disruption cassette was constructed
by an overlap PCR method using primers TL2061, TL2062, TL2063,
TL2064, TL2065 and TL2066, along with strain H99 genomic DNA
and the plasmid pCH233 as templates [59,60]. The construct was
biolistically transformed into the wild-type strain as described
previously [61]. Positive transformants were identiﬁed by PCR,
conﬁrmed by Southern blot analysis and named TLF1–9 (Figure
S3A). To reconstitute the cft1 mutant, primers H9F1RCF and
H9F1RCR were used to amplify the wild type CFT1 gene from
genomic DNA. The PCR fragments were digested with SacI and SpeI,
and cloned into pJAF to construct pWH045 containing the neomycin
resistant marker (NEO). The plasmid pWH045 was digested with NdeI
and transformed into the cft1 mutant. Positive transformants
containing the wild-type CFT1 at its authentic locus were identiﬁed
by PCR and named CFT1R9–4. To construct the cft2 mutant, the
genomic region of 2010 bp that corresponds to the entire coding
sequence of CFT2 was replaced by a disruption cassette containing
the NEO marker using 5’ and 3’ ﬂanking sequences of CFT2. Primers
TL2071, TL2072, TL2073, TL2074, TL2075 and TL2076 were used for
construction of the disruption cassette by an overlap PCR method
and H99 genomic DNA and the plasmid pJAF were used as templates
[59,60]. The construct was transformed as described above and
positive transformants were identiﬁed by PCR, conﬁrmed by South-
ern blot analysis and named TLF2–9 (Figure S3B). To reconstitute the
cft2 mutant, primers H9F2RCFBglII and H9F2RCRBglII were used to
amplify the wild type CFT2 gene. The PCR fragments were digested
with BglII and cloned into BamHI digested pCH233 to construct
pWH056 containing the NAT marker. The plasmid pWH056 was
digested with NdeI and transformed into the cft2 mutant. Positive
transformants containing the wild-type CFT2 at its authentic locus
were identiﬁed by PCR and named CFT2R9–2. The cft1 cft2 double
mutants were constructed by transforming the CFT2 disruption
cassette into the cft1 mutant. The positive transformants were
selected by PCR, conﬁrmed by Southern blot analysis and named
cft1D cft2D (Figure S3C).
Iron uptake assays. Iron uptake assays were performed as
described previously with minor modiﬁcations [62,63]. Brieﬂy, cells
were grown in YNB medium overnight, transferred to YNB medium
containing 1 mM ascorbic acid and 1mM ferrozine and incubated at
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7 cells
were withdrawn from each culture, centrifuged and washed once with
uptake buffer (0.2 M 3-(N-Morpholino)-propanesulfonic acid (MOPS),
2% glucose, 20 mM Na-citrate pH 6.8). Cells were resuspended in 0.5
ml of uptake buffer and kept at room temperature for 15 min for
equilibration. Uptake buffer (0.5 ml) containing 20 lMo f
55FeCl3was
added to each sample, and the cells were incubated for 30 min at room
temperature. After incubation, 5 ml of quenching buffer (0.375 M
Succinic acid, 0.625 M Tris, 0.128 M EDTA, pH 6.0) was added, and
each sample was immediately vacuum-aspirated through a GF/A ﬁlter
(Whatman). The ﬁlter was washed with 20 ml of quenching buffer, and
radioactivity was measured by liquid scintillation counting.
The uptake of iron from transferrin was performed as described
previously [13]. Brieﬂy, human apo-transferrin was purchased from
Sigma and 55Fe labelled transferrin was prepared by the addition of a
threefold molar excess of
55FeCl3 to 10 lM apo-transferrin in
transferrin loading buffer (0.1 M HEPES, pH 7.5, 0.15 M sodium
chloride, and 10 mM sodium bicarbonate). The reaction mix was
incubated for 30 min at 228C and 30 min on ice, and the labelled
transferrin was separated from unbound
55Fe using Sephadex G-25
spin columns. Cells were grown to mid log phase in the presence of
300 lM Ferrozine. They were then washed three times with citrate-
glucose buffer (0.1 M Morpholinethanesulfonic acid (MES) buffer pH
6.0, 20 mM Na-citrate, 2% glucose) and resuspended in the same
buffer followed by incubation in a 308C water bath for 15 min prior
to the addition of 2 lM
55Fe-transferrin. After 1 h, samples were
removed and quenched using 3 ml of quenching buffer. The free iron
was removed by washing and the
55Fe radioactivity associated with
the cells was measured by liquid scintillation counting on Wallac 1409
liquid scintillation counter.
Quantitative real-time RT-PCR. Primers for real-time RT-PCR
analysis were designed using Primer Express software 3.0 (Applied
Biosystems) and are listed in Table S3. Cell cultures were prepared by
growth in low-iron medium as described above, and then transferred
to the same medium containing different concentrations of iron
sources as indicated in the text. Total RNA was puriﬁed with the
RNeasy kit (Qiagen), treated with DNAse (Qiagen) and cDNA was
generated using the SuperScript First-Strand Synthesis System
(Invitrogen). PCR reactions were monitored as described previously
[33], and relative gene expression was quantiﬁed using the SDS
software 1.3.1 (Applied Biosystems) based on the 2
-DDCT method [64].
ACT1 was used as a control for normalization.
Virulence assays. To examine virulence in an inhalation model of
cryptococcosis, strains were cultured in 5 ml YPD overnight at 308C.
The overnight cultures were washed twice with PBS, and the fungal
cells were resuspended in PBS. 4–6 week old female A/Jcr mice were
anesthetized intraperitoneally with ketamine (80 mg/kg) and xylazine
(5.5 mg/kg) in saline, and suspended on a silk thread by the superior
incisors. A cell suspension of 5310
4 cells in 50 ll was slowly dripped
into the nares of the anesthetized mice, and the mice were suspended
for 10 min on the thread. For the tail vein injection model, strains
were directly injected in the lateral tail veins of mice at a density of 5
3 10
4 cells in 200 ll of PBS. The status of the mice was monitored
daily post-inoculation. Mice reaching the humane endpoint were
euthanized by CO2 anoxia. To assess fungal burden of organs from
mice infected by inhalation or tail vein injection, three mice were
used for each strain at each time point. Mice were euthanized with
CO2, four organs including the brain, the lungs, the liver and the
spleen, were aseptically removed and soaked in 0.5 ml PBS overnight
at 48C. Organs were homogenized manually with a sterile plastic
pestle. Cell strainers (BD, 70 lm Nylon) were used to remove tissue
debris in the samples. The samples were serially diluted and 200 llo f
the diluted samples were plated and spread with sterile 4 mm glass
beads on YPD plates containing chloramphenicol (35 lg/ml). CFUs
were determined after three days of incubation at 308C.
The following method was used to examine the timing of
dissemination to the brain and lungs following tail vein injection.
Cells were cultured in 5 ml of YPD overnight at 308C, washed twice
with PBS, and resuspended in PBS. Cell counts were performed with a
haemocytometer. A total of 28 6-week-old female A/Jcr mice were
inoculated with 200 ll of the wild-type strain H99 or the cft1 mutant
(2.5 3 10
5 cells/ml in PBS). The brain and the lungs of the mice were
harvested aseptically on days 1, 2 and 3 post-inoculation. The organs
were manually homogenized in 1 ml PBS with sterile plastic pestles.
Cell strainers (BD, 70 lm nylon) were used to remove tissue debris in
the samples. The samples were serially diluted and 200 ll of the
dilutions were plated followed by incubation at room temperature
for 3 days.
The protocols for the virulence assays (protocol A99–0252)
conformed to regulatory standards of and was approved by the
University of British Columbia Committee on Animal Care.
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